Part 3: Jurisdictions: Federal/States
Who should attend: All clinical trial stakeholders, including sites, sponsors and CROs, HREC & governance officers.
In response to the risk to clinical trials, ARCS is running free weekly webinars focused on COVID-19. These are going to be highly effective in helping everyone understand what is happening and what strategies different groups are adopting to keep our trials going as effectively as possible. The webinar series is called 'COVID-19: considerations and strategies for running trials during the pandemic'.
The purpose of this webinar series is to provide information, advice, and a chance to discuss how COVID-19 will impact clinical trials in Australia. There will be 10 webinars, each targeted at a different clinical trials area, as follows:
23-Mar-2020: Part 1 - Investigators and Study Coordinators
31-Mar-2020: Part 2 - Peak Bodies and TGA
06-Apr-2020: Part 3 - Jurisdictions: Federal/States
20-Apr-2020: Part 4 - Ethics Committees and Governance
28-Apr-2020: Part 5 - Role of Clinical Trial Sponsors
04-May-2020: Part 6 – Academics
11-May-2020: Part 7 – Private Sector
18-May-2020: Part 8 - Pharmacovigilance and Regulatory Affairs
25-May-2020: Part 9 - Clinical Trials for COVID-19 Treatment and Prevention
01-Jun-2020: Part 10 – Trial Participants
Please direct all questions regarding this webinar and its content to: arcs@arcs.com.au
Latest Resources
Latest Events
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Role of Clinical Trial Sponsors & COVID-19: considerations and strategies for running trials during the pandemic
-
Tweetchats with PRAXIS and ACTA
-
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic